Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema

Japanese Journal of Ophthalmology

Volumn 46, Issue 1, 2002, Pages 78-83

  Shimizu, Erika ^a,d   Funatsu, Hideharu ^a   Yamashita, Hidetoshi ^b   Yamashita, Tetsuji ^c   Hori, Sadao ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c MITSUBISHI CHEMICAL CORPORATION   (Japan)

^d Tokyo Wom en's Medical University   (Japan)

Author keywords

Diabetic retinopathy; Interleukin 6; Macular edema; Posterior vitreous detachment

Indexed keywords

INTERLEUKIN 6; LIPOPROTEIN; THROMBOMODULIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXUDATE; EYE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROTEIN BLOOD LEVEL; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; RISK; RISK FACTOR; VITREOUS BODY DETACHMENT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERLEUKIN-6; LIPOPROTEIN(A); LYMPHOKINES; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; THROMBOMODULIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON WILLEBRAND FACTOR;

EID: 0036184009     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-5155(01)00452-X     Document Type: Article

References (39)

1. The Wisconsin epidemiological study of diabetic retinopathy. XV. The long-term incidence of macular edema
2. A critical review highlighting diffuse macular edema
3. Macular edema and cystoid macular edema
4. Diabetic macular edema
5. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
6. Roles of cytokines in diabetic retinopathy
7. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
8. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
9. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy
10. Elevated γ-amino-butyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
11. Interleukin 6 induces the expression of vascular endothelial growth factor
12. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels
13. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas
14. 2 in the vitreous in proliferative diabetic retinopathy
15. Hepatocyte growth factor in vitreous fluid of patients with proliferative diabetic retinopathy and other retinal disorders
16. The role of the vitreous in diabetic macular edema
17. Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus
18. Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction
19. Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane
20. Grading diabetic retinopathy from stereoscopic color fundus photographs, An extension of the modified Airlie House classification, ETDRS report number 10
21. Classification of diabetic retinopathy from fluorescein angiograms, ETDRS report number 11
22. Fundus photographic risk factors for progression of diabetic retinopathy, ETDRS report number 12
23. Cytokines in the vitreous of patients with proliferative diabetic retinopathy
24. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy
25. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy
26. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
27. Expression of vitreous cytokines in proliferative vitreoretinopathy, A prospective study
28. Interleukin-6 and the acute phase response
29. Biological and clinical aspects of interleukin 6
30. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorder
31. Cytokines in vitreous humor: Interleukin-6 is elevated in proliferative vitreoretinopathy
32. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro
33. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells
34. Early breakdown of the blood-retinal barrier in diabetes
35. Effects of tumor necrosis factor-α and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells
36. The influence of cytokines on the integrity of the blood-brain barrier in vitro
37. Experimental acute pancreatitis results in increased blood-brain barrier permeability in the rat: A potential role for tumor necrosis factor and interleukin 6